首页543904 • BOM
add
Mankind Pharma Ltd
昨日收盘价
₹2,628.25
当日价格范围
₹2,594.45 - ₹2,730.00
年度波幅
₹1,685.00 - ₹2,839.00
市值
1.07万亿 INR
平均交易量
1.89万
市盈率
54.42
股息率
-
主要交易所
NSE
市场资讯
财务信息
损益表
收入
净收入
(INR) | 2024年6月info | 年同比变化 |
---|---|---|
收入 | 289.34亿 | 12.21% |
经营支出 | 150.69亿 | 26.50% |
净收入 | 53.65亿 | 10.19% |
净利润率 | 18.54 | -1.80% |
每股收益 | 13.37 | 10.13% |
息税折旧摊销前利润 | 67.02亿 | 3.28% |
有效税率 | 18.66% | — |
资产负债表
总资产
负债总额
(INR) | 2024年6月info | 年同比变化 |
---|---|---|
现金及短期投资 | 338.65亿 | 121.53% |
总资产 | — | — |
负债总额 | — | — |
权益总额 | 957.58亿 | — |
发行在外的股份 | 4.01亿 | — |
市净率 | 11.24 | — |
资产回报率 | — | — |
资本回报率 | 14.67% | — |
现金流
现金净变动
(INR) | 2024年6月info | 年同比变化 |
---|---|---|
净收入 | 53.65亿 | 10.19% |
来自运营的现金 | — | — |
投资现金 | — | — |
融资现金 | — | — |
现金净变动 | — | — |
自由现金流 | — | — |
简介
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
CEO
成立时间
1991
员工数量
19,540